Trial Profile
Open-Label, Single-Centre, Randomised Pilot Study to Evaluate Immunovirological and Clinical Evolution of a Combination With Nucleoside Analogues/Nucleotides (Trizivir +Tenofovir) in Multiresistant Patients With Virological Failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Lamivudine/zidovudine/abacavir (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals; Enfuvirtide; Lamivudine; Lopinavir; Tipranavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms TETRIZ
- 09 Nov 2008 Results were presented at the 9th International Congress on Drug Therapy in HIV Infection.
- 11 Jul 2007 Status change from in progress to complete.
- 01 Nov 2006 New trial record.